Table 3

- Distribution of positron emission tomography/computed tomography (PET/CT) findings on different body involved areas (N=39).

ParametersFirst PET/CT(n=37)Second PET/CT(n=37)Third PET/CT(n=20)
PET/CT done37 (100)37 (100)20 (100)
Therapy status   
Post chemotherapy37 (100)37 (100)20.0 (100)
Number of lesions   
<512 (32.4)19 (51.6)6.0(30.0)
≥5 and <105 (13.5)6 (18.2)0
≥1019 (51.4)4 (12.1)2.0(10.0)
No bony lesion1 (2.7)8 (21.6)12.0(60.0)
Skull, mean±SD2.6±6.020.2±1.040.3±1.52)
Spine, mean±SD6.5±6.952.3±3.001.8±2.72)
Upper limbs including scapula, mean±SD5.1±8.512.2±6.970.9±2.45
Lower limbs, mean±SD4.8±9.141.5±4.520.8±2.31
Pelvic bones, mean±SD7.1±8.102.4±2.661.9±2.42
Ribs + sternum, mean±SD6.3±5.502.16±2.581.9±2.59
Patterns of bone lesion   
Lytic19 (51.4)17 (46.0)12 (60.0)
lytic lesion with soft tissue12 (32.4)4 (10.8)1 (5.0)
Lytic and sclerotic3 (8.1)12 (32.4)5 (25.0)
Sclerotic1 (2.7)2 (5.4)1 (5.0)
Diffuse osteopenia1 (2.7)0.0 
No bone lesion1 (2.7)2 (5.4)1 (5.0)
Lymph nodes (presents)2 (5.4)2 (5.4)1 (5.0)
Organs involved   
No organ involved30 (81.1)019 (95.0)
Liver2 (5.4)2 (5.4)1 (5.0)
Spleen2 (5.4)30 (81.1)0
Soft tissue1(2.7)5 (13.5)0
Nasopharynx and lungs1 (2.7)00
Pancreas1 (2.7)00
  • Values are presented as number and percentages (%) unless otherwise stated. SD: standard deviation